RecruitingPhase 4NCT04460521

The ACTS Trial: N-acetylcysteine (NAC) and Night-splinting as a Non-operative Treatment for Carpal Tunnel Syndrome

Studying NON RARE IN EUROPE: Carpal tunnel syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Emily Krauss
Principal Investigator
Michael Bezuhly, MD
NSHA
Intervention
N-Acetyl cysteine(drug)
Enrollment
240 enrolled
Eligibility
18 years · All sexes
Timeline
20222026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04460521 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Carpal tunnel syndrome

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Carpal tunnel syndrome

← Back to all trials